Article Versions Notes

Freudenstein D, Litchfield C, Caramia F, Wright G, Solomon BJ, Ball D, Keam SP, Neeson P, Haupt Y, Haupt S. TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival. Cancers. 2020; 12(6):1535. https://doi.org/10.3390/cancers12061535

Freudenstein, Donald, Cassandra Litchfield, Franco Caramia, Gavin Wright, Benjamin J. Solomon, David Ball, Simon P. Keam, Paul Neeson, Ygal Haupt, and Sue Haupt. 2020. "TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival" Cancers 12, no. 6: 1535. https://doi.org/10.3390/cancers12061535

Freudenstein, D., Litchfield, C., Caramia, F., Wright, G., Solomon, B. J., Ball, D., Keam, S. P., Neeson, P., Haupt, Y., & Haupt, S. (2020). TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival. Cancers, 12(6), 1535. https://doi.org/10.3390/cancers12061535